ArticleCrohn's & colitis 360Published
Efficacy and Safety of Mirikizumab in the Treatment of Moderately to Severely Active Ulcerative Colitis Regardless of Baseline Modified Mayo Score: Results From the Phase 3 LUCENT Trials
Regional connection
Verified Author affiliations on the Europe PMC record name Lewis Katz School of Medicine, Temple University. Affiliation source
- Institutions
- Lewis Katz School of Medicine, Temple University
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Crohn's & colitis 360
- Published
- Topic
- Clinical care
- Subject terms
- Fatigue; Ulcerative colitis; Urgency; Mirikizumab; Modified Mayo Score
- PubMed ID
- 40260308
- PubMed Central ID
- PMC12010086
- Open access
- Yes, open
- Added to directory
- Source checked